AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29924310 — intervention group
Group type: EXPERIMENTAL
Intervention: Tychem® C Standard
Number of subjects: 42
Study 26868123 — intervention group
Group type: EXPERIMENTAL
Intervention: 4000 IU D3 daily for 6 months
Number of subjects: 116
Study 26868123 — intervention group
Group type: COMPARATOR
Intervention: 600 IU D3 daily for 6 months
Number of subjects: 116
Study 25775024 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP chemotherapy in combination with Ofatumumab (CHOP-O)
Number of subjects: 25
Study 25775024 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab maintenance therapy
Number of subjects: 25
Study 23090424 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent drain clamping with injection of diluted epinephrine solution (Group I)
Number of subjects: 100
Study 23090424 — intervention group
Group type: COMPARATOR
Intervention: Nonclamping without injection of diluted epinephrine solution (Group II)
Number of subjects: 100
Study 23090424 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 21256799 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (optimized at 0.125, 0.25, 0.50, or 0.75 mg/day)
Number of subjects: 755
Study 21256799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 755
Study 19376750 — intervention group
Group type: EXPERIMENTAL
Intervention: Light pressure effleurage massage
Number of subjects: 30
Study 19376750 — intervention group
Group type: COMPARATOR
Intervention: Control visit (equal amount of attention)
Number of subjects: 30
Study 16569981 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized videotapes
Number of subjects: 214
Study 16569981 — intervention group
Group type: COMPARATOR
Intervention: Standard videotapes
Number of subjects: 214
Study 16569981 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 214
Study 12920388 — intervention group
Group type: EXPERIMENTAL
Intervention: Reboxetine
Number of subjects: 19
Study 12920388 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 19
Study 11104118 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g/kg alcohol
Number of subjects: 20
Study 11104118 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g/kg alcohol
Number of subjects: 20
Study 11104118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9114143 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin and ciprofloxacin
Number of subjects: 131
Study 9114143 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone and doxycycline
Number of subjects: 131
Study 1586604 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (cyclophosphamide 1,000 mg m‐2 i.v., doxorubicin 50 mg m‐2 i.v., vincristine 1.4 mg m‐2 i.v., and prednisolone 40 mg orally for 5 days, given 3 weekly for four cycles) + Radiotherapy (CHOP + RT)
Number of subjects: 76
Study 1586604 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (RT)
Number of subjects: 76
Study 1586604 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CHOP + RT)
Number of subjects: 76
Study 2872569 — intervention group
Group type: EXPERIMENTAL
Intervention: L-363,586 (10 micrograms/hr)
Number of subjects: 6
Study 2872569 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin (200 micrograms/hr)
Number of subjects: 6
Study 2872569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 29346831 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual external ventricular drain (EVD)
Number of subjects: 0
Study 29346831 — intervention group
Group type: COMPARATOR
Intervention: Single external ventricular drain (EVD)
Number of subjects: 0
Study 27570088 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (1000 mg single dose)
Number of subjects: 201
Study 27570088 — intervention group
Group type: COMPARATOR
Intervention: Standard care (observation)
Number of subjects: 201
Study 24170101 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estrogen treatment for 3 weeks
Number of subjects: 20
Study 22904179 — intervention group
Group type: EXPERIMENTAL
Intervention: GH 2 mg/m(2) · d during puberty
Number of subjects: 121
Study 22904179 — intervention group
Group type: COMPARATOR
Intervention: GH/GnRHa
Number of subjects: 121
Study 21275161 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-step acupuncture (TSA) combined with small dosage antipsychotic
Number of subjects: 60
Study 21275161 — intervention group
Group type: COMPARATOR
Intervention: Full-dose antipsychotic
Number of subjects: 60
Study 18955423 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional strength training group (n = 8)
Number of subjects: 18
Study 18955423 — intervention group
Group type: COMPARATOR
Intervention: Training-as-usual group (n = 10)
Number of subjects: 18
Study 16941276 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-18 levels in subjects with arterial hypertension
Number of subjects: 261
Study 16941276 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of waist to hip ratio with IL-18
Number of subjects: 261
Study 16941276 — intervention group
Group type: COMPARATOR
Intervention: IL-18 levels in obese vs normal-weight individuals
Number of subjects: 261
Study 12883781 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified long gamma nail (LGN10)
Number of subjects: 50
Study 12883781 — intervention group
Group type: COMPARATOR
Intervention: Long gamma nail (LGN11)
Number of subjects: 50
Study 10871975 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 359
Study 10871975 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg once daily
Number of subjects: 359
Study 10871975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 359
Study 9148548 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow fever vaccination
Number of subjects: 24
Study 9148548 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study 8256728 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior wall AMI
Number of subjects: 3981
Study 8256728 — intervention group
Group type: COMPARATOR
Intervention: Inferior wall AMI
Number of subjects: 3981
Study 3846198 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose treatment with amoxicillin (3.0 g single dose)
Number of subjects: 31
Study 3846198 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with amoxicillin (250 mg three times daily for ten days)
Number of subjects: 31
Study 31888504 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of remifentanil (group R)
Number of subjects: 80
Study 31888504 — intervention group
Group type: COMPARATOR
Intervention: Epidural group (group E)
Number of subjects: 80
Study 28213783 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (doxorubicin, 5-fluorouracil/mitomycin, or epirubicin)
Number of subjects: 364
Study 28213783 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (paclitaxel)
Number of subjects: 364
Study 24943918 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction for breast cancer survivors (MBSR(BC))
Number of subjects: 79
Study 23392199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction (two-thirds of normal sleep time for 8 days/8 nights)
Number of subjects: 0
Study 23392199 — intervention group
Group type: COMPARATOR
Intervention: Usual sleep (control group)
Number of subjects: 0
Study 23392199 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep restriction
Number of subjects: 0
Study 22186687 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass fiber
Number of subjects: 45
Study 22186687 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene fiber
Number of subjects: 45
Study 22186687 — intervention group
Group type: COMPARATOR
Intervention: Z250 composite resin without fibers (Control)
Number of subjects: 45
Study 19536690 — intervention group
Group type: EXPERIMENTAL
Intervention: Observer perspective memories
Number of subjects: 123
Study 19536690 — intervention group
Group type: EXPERIMENTAL
Intervention: Field perspective memories
Number of subjects: 123
Study 16441931 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed complementary food (PCF)
Number of subjects: 158
Study 16441931 — intervention group
Group type: COMPARATOR
Intervention: Unprocessed complementary food (UPCF)
Number of subjects: 158
Study 15065100 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision analysis consultation
Number of subjects: 117
Study 15065100 — intervention group
Group type: COMPARATOR
Intervention: Routine consultation
Number of subjects: 117
Study 11132761 — intervention group
Group type: EXPERIMENTAL
Intervention: IV vitamin C 500 mg administered three times a week for three months
Number of subjects: 27
Study 11132761 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vitamin C for the first three months)
Number of subjects: 27
Study 11132761 — intervention group
Group type: EXPERIMENTAL
Intervention: IV vitamin C 500 mg administered three times a week for the second three months
Number of subjects: 27
Study 9060568 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate solution
Number of subjects: 97
Study 9060568 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 97
Study 8453970 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (3 g)
Number of subjects: 6
Study 8453970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin (400 mg)
Number of subjects: 6
Study 3513209 — intervention group
Group type: EXPERIMENTAL
Intervention: PGE2 vaginal film (850 ug)
Number of subjects: 111
Study 3513209 — intervention group
Group type: COMPARATOR
Intervention: Forewater amniotomy and I.V. oxytocin
Number of subjects: 111
Study 30562268 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. morphine (0.09-mg/kg total)
Number of subjects: 46
Study 30562268 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. naloxone (12-mg total)
Number of subjects: 46
Study 30562268 — intervention group
Group type: COMPARATOR
Intervention: saline placebo
Number of subjects: 46
Study 29717840 — intervention group
Group type: EXPERIMENTAL
Intervention: TRUSC-guided administration of traditional Chinese medicine, qd for 7 days before TURP
Number of subjects: 167
Study 29717840 — intervention group
Group type: COMPARATOR
Intervention: TURP only (Control)
Number of subjects: 167
Study 29717840 — intervention group
Group type: EXPERIMENTAL
Intervention: TRUSC-guided administration of traditional Chinese medicine
Number of subjects: 167
Study 25458745 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch 130/0.4 (Group HES)
Number of subjects: 30
Study 25458745 — intervention group
Group type: COMPARATOR
Intervention: Isolyte S® (Group ISO)
Number of subjects: 30
Study 23570300 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek Silorane Restorative System
Number of subjects: 25
Study 23570300 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Scotchbond 1 XT with Filtek Z250
Number of subjects: 25
Study 23570300 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Scotchbond SE with Filtek Z250
Number of subjects: 25
Study 23570300 — intervention group
Group type: EXPERIMENTAL
Intervention: All systems
Number of subjects: 25
Study 21355158 — intervention group
Group type: EXPERIMENTAL
Intervention: String puncture combined with electroacupuncture
Number of subjects: 95
Study 21355158 — intervention group
Group type: COMPARATOR
Intervention: Routine manipulations (control group)
Number of subjects: 95
Study 18359021 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 120
Study 18359021 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 120
Study 16825669 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (asthma coaching + monetary incentive)
Number of subjects: 92
Study 16825669 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual discharge instructions)
Number of subjects: 92
Study 12825062 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg diazepam and 0.015 mg/kg atropine sulfate
Number of subjects: 50
Study 12825062 — intervention group
Group type: COMPARATOR
Intervention: No premedication
Number of subjects: 50
Study 10942103 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital intervention utilizing medical opinion leaders and performance feedback
Number of subjects: 28
Study 10942103 — intervention group
Group type: COMPARATOR
Intervention: Performance feedback only (Control)
Number of subjects: 28
Study 8696444 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival curves and relative risk estimates derived from a proportional hazards analysis
Number of subjects: 0
Study 8696444 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors (sex, age)
Number of subjects: 0
Study 1646881 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcuticular polyglycolic acid
Number of subjects: 126
Study 1646881 — intervention group
Group type: COMPARATOR
Intervention: Interrupted monofilament nylon mattress sutures
Number of subjects: 126
Study 1646881 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall infection rate
Number of subjects: 126
Study 1646881 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedures by surgeons with highest infection rates
Number of subjects: 126
Study 1646881 — intervention group
Group type: COMPARATOR
Intervention: Procedures by remaining surgeons
Number of subjects: 126
Study 6661346 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg AQ‐A 39
Number of subjects: 10
Study 6661346 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg AQ‐A 39
Number of subjects: 10
Study 6661346 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6661346 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 10
Study 6661346 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 10
Study 30085285 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief pain screening measures
Number of subjects: 24
Study 30131099 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telemonitoring for blood pressure delivered by a team comprising a GP, a hypertension specialist, a general nurse and an information manager.
Number of subjects: 110
Study 30131099 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 110
Study 30131099 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telemonitoring (intervention group).
Number of subjects: 110
Study 26655084 — intervention group
Group type: EXPERIMENTAL
Intervention: NS11821 (10 mg, 30 mg, 75 mg, 150 mg, 300 mg, 600 mg)
Number of subjects: 48
Study 25834495 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation programme (PRP) for 6 weeks
Number of subjects: 67
Study 25834495 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study 22785325 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfamethazine (SMZ) 0.2%
Number of subjects: 0
Study 22785325 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 0
Study 20814315 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose risperidone plus low-dose haloperidol (2 mg/d risperidone + 2 mg/d haloperidol)
Number of subjects: 88
Study 20814315 — intervention group
Group type: COMPARATOR
Intervention: Risperidone monotherapy (4 mg/d risperidone)
Number of subjects: 88
Study 17905486 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis A vaccine (VAQTA) administered at 6 and 12 months of age
Number of subjects: 0
Study 17905486 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexavalent vaccine (HEXAVAC) administered at 2, 4, 6, and 12 months of age
Number of subjects: 0
Study 15677625 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy plus ovarian suppression (either radiation-induced ovarian ablation or triptorelin for 3 years)
Number of subjects: 926
Study 15677625 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy alone (control arm)
Number of subjects: 926
Study 15677625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovarian suppression in patients <40 years of age with estrogen receptor-positive tumors
Number of subjects: 926
Study 12407637 — intervention group
Group type: EXPERIMENTAL
Intervention: Total homocysteine (tHcy) levels
Number of subjects: 804
Study 12407637 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteine levels
Number of subjects: 804
Study 12407637 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamin levels (folate, PLP, vitamin B12)
Number of subjects: 804
Study 10334434 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 0
Study 10334434 — intervention group
Group type: COMPARATOR
Intervention: Angioplasty
Number of subjects: 0
Study 8624122 — intervention group
Group type: EXPERIMENTAL
Intervention: Besipirdine 5 mg BID
Number of subjects: 275
Study 8624122 — intervention group
Group type: EXPERIMENTAL
Intervention: Besipirdine 20 mg BID
Number of subjects: 275
Study 8624122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study 8624122 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical global rating
Number of subjects: 275
Study 1923396 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical medication containing tannic acid
Number of subjects: 26
Study 1923396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 6978010 — intervention group
Group type: EXPERIMENTAL
Intervention: Conray 60
Number of subjects: 40
Study 6978010 — intervention group
Group type: COMPARATOR
Intervention: Sinografin
Number of subjects: 40
Study 30721296 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG-guided anesthetic administration
Number of subjects: 1232
Study 30721296 — intervention group
Group type: COMPARATOR
Intervention: Usual anesthetic care
Number of subjects: 1232
Study 28346333 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 60
Study 28346333 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil with primrose evening oil supplementation
Number of subjects: 60
Study 28346333 — intervention group
Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 60
Study 26715763 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic resistance training using resistance elastic bands in a seated position during the first hour of haemodialysis treatment for 12, 24 or 36 weeks
Number of subjects: 171
Study 24788929 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm climate rehabilitation programme
Number of subjects: 132
Study 24788929 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold climate rehabilitation programme
Number of subjects: 132
Study 24788929 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 132
Study 22760081 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment
Number of subjects: 60
Study 19527468 — intervention group
Group type: EXPERIMENTAL
Intervention: Polaprezinc (34 mg/day)
Number of subjects: 117
Study 17264781 — intervention group
Group type: EXPERIMENTAL
Intervention: rh-TSH treated patients (17 patients)
Number of subjects: 46
Study 17264781 — intervention group
Group type: COMPARATOR
Intervention: Hypothyroid patients (14 patients)
Number of subjects: 46
Study 17264781 — intervention group
Group type: EXPERIMENTAL
Intervention: rh-TSH treated patients (10 patients)
Number of subjects: 46
Study 17264781 — intervention group
Group type: COMPARATOR
Intervention: Hypothyroid patients (21 patients)
Number of subjects: 46
Study 17264781 — intervention group
Group type: EXPERIMENTAL
Intervention: rh-TSH treated patients
Number of subjects: 46
Study 17264781 — intervention group
Group type: COMPARATOR
Intervention: Hypothyroid patients
Number of subjects: 46
Study 15554347 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler with pCO2 challenge
Number of subjects: 17
Study 15554347 — intervention group
Group type: COMPARATOR
Intervention: Age-matched healthy nondiabetic controls
Number of subjects: 17
Study 11475220 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (100% atmospheres, 3 litres/minute) for 24 hours
Number of subjects: 550
Study 11475220 — intervention group
Group type: COMPARATOR
Intervention: Control (no additional oxygen)
Number of subjects: 550
Study 9330939 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation of AC joints
Number of subjects: 95
Study 9330939 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 95
Study 9330939 — intervention group
Group type: COMPARATOR
Intervention: MRI
Number of subjects: 95
Study 9330939 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 95
Study 9330939 — intervention group
Group type: COMPARATOR
Intervention: Radiography
Number of subjects: 95
Study 7903217 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertatolol
Number of subjects: 0
Study 7903217 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study 3519285 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 courses of a 'CMF like' chemotherapy
Number of subjects: 248
Study 3519285 — intervention group
Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 248
Study 3146465 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fusidate ointment
Number of subjects: 354
Study 3146465 — intervention group
Group type: COMPARATOR
Intervention: Mupirocin ointment
Number of subjects: 354
Study 31437703 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 57
Study 31437703 — intervention group
Group type: COMPARATOR
Intervention: Escitalopram/Venlafaxine
Number of subjects: 57
Study 25935145 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.33% ropivacaine by pump through the wound
Number of subjects: 71
Study 25935145 — intervention group
Group type: COMPARATOR
Intervention: Intravenous delivery of flurbiprofen axetil, pentazocine and palonosetron via intravenous pump
Number of subjects: 71
Study 25437180 — intervention group
Group type: COMPARATOR
Intervention: Ensure Liquid (EL)
Number of subjects: 27
Study 25437180 — intervention group
Group type: EXPERIMENTAL
Intervention: Inner Power (IP)
Number of subjects: 27
Study 25437180 — intervention group
Group type: EXPERIMENTAL
Intervention: EL + IP
Number of subjects: 27
Study 23298553 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-enrolled patients in thromboprophylaxis trial
Number of subjects: 3746